Your assumptions are very possible IMO. The timing of DTC coincides with mid year formulary changes, more rep visits, more peer conferences and educational absorption. And they all follow the court decision and the FDA label expansion. Nice and tidy by mid year with a positive court decision. Why not?
News 
Market Data 
Discover 
